Enliven Therapeutics (ELVN) Q3 2019 Earnings

8OctExpected
Q3 2019
-0.32
-0.21
-0.11
0

Details

Expected EPS
0
Actual EPS
-0.32
Surprise EPS
-0.32
Surprise Percent
+∞%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.32 per share for Q3 2019.

0 Comments

Share your thoughts